Saturday, February 29, 2020 5:20:59 PM
https://stocktwits.com/OneLifeToLive/message/197475582
https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1
Recent TNXP News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2024 01:05:23 PM
- Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia • GlobeNewswire Inc. • 12/23/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2024 09:17:53 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/20/2024 09:16:37 PM
- This Micro Cap Is Getting Bid Up Prior To Opening Bell • AllPennyStocks.com • 12/17/2024 02:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 01:05:36 PM
- Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia • GlobeNewswire Inc. • 12/17/2024 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/06/2024 09:13:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/03/2024 12:05:23 PM
- Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires • GlobeNewswire Inc. • 12/03/2024 12:00:00 PM
- Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference • GlobeNewswire Inc. • 11/26/2024 12:00:00 PM
- Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual • GlobeNewswire Inc. • 11/18/2024 09:05:00 PM
- Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting • GlobeNewswire Inc. • 11/18/2024 12:00:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 09:42:22 PM
- Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting • GlobeNewswire Inc. • 11/13/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 02:10:11 PM
- Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals • GlobeNewswire Inc. • 11/13/2024 02:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 10:10:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 01:05:29 PM
- Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights • GlobeNewswire Inc. • 11/12/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2024 10:15:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 12:30:21 PM
- Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya • GlobeNewswire Inc. • 11/04/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 11:05:20 AM
Basanite, Inc. to Open New Production and Distribution Facility in Northeast Ohio • BASA • Jan 2, 2025 8:28 AM
The Crypto Company Highlights Blockchain Training Alliance's Successes and Momentum for 2025 • CRCW • Dec 26, 2024 8:58 AM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM